TOIIW_OUT_1 [2025-04-24 12:30:54 -0400] 3323 Bytes | 792 tokens | Cum: 792 tkns (9.90% of 8k)
==========================================================================

Listen up, partner—it's 12:30 PM on Thu Apr 24, 2025, and I’m revved up about The Oncology Institute (TOIIW), climbing from $0.0625 to $0.1762. This stock is buzzing big-time—do we have a hidden gem, or a flash in the pan? Help me sift through the data!

--- COMPANY PROFILE ---
Company: The Oncology Institute (TOIIW)
IPO: 2021-11-15 (3 Years Ago)
Shares Outstanding: 75,740,000
Industry: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE
Exchange: XNAS
Description: The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.

Here’s a list of headlines for The Oncology Institute:

No news available.

Here's another list of headlines with menu handles.
I will deliver the full text of the following stories when you say their handle.
Just say, for example, B1, B2, etc.

B1 - 2025-03-24T10:00:00Z - The Oncology Institute Announces $16.5 million Private Placement
B2 - 2024-11-21T12:00:00Z - Grapevine Saves The Oncology Institute Millions On Healthcare Supplies
B3 - 2024-04-04T12:00:00Z - The Oncology Institute and Healthly Forge Strategic Alliance to Elevate Cancer Care Access to Healthly Patients Across Southern California
B4 - 2024-03-27T20:05:00Z - The Oncology Institute Reports Fourth Quarter and Full Year 2023 Financial Results and Guidance for 2024
B5 - 2024-03-14T12:09:00Z - MaxHealth & The Oncology Institute Expand Value-Based Care Partnership
B6 - 2024-03-06T13:00:00Z - The Oncology Institute Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Conference Call

==============
-> THE ROLE FOR AI:
==============

1) You are the **AI analyst-investigator**, and this interaction represents a full **due diligence session** for The Oncology Institute (TOIIW).
Due diligence includes financial data, insider trading, relevant news, and any SEC filings — and may extend beyond classic fundamentals.
Your task is to identify whether this stock has momentum and potential.

2) I am **ScanScor**, a unified report generator that archives this session as part of our real-time diligence record.

3) You will request information by referencing documents by their code.

4) As the analysis proceeds, your are encouraged to review documents until you feel confident in your judgment.
After seeing 3 sets of news articles, SEC docs, and financials, you'll be prompted to return some data pairs.

5) News articles, SEC filings, and key metrics will be revealed in subsequent prompts.

Stay focused. Gather evidence. Continue until your conclusions are clear.
Restrict all your responses to just 3 tokens until the summary and data pairs at the end.

NEXT: Request a document with its reference code(s), such as:
- `B1`, `B2`, `B3`, etc.
- To load a new set of information and menu options, reply with: `NEX`

TOIIW_OUT_3 [2025-04-24 12:30:55 -0400] 876 Bytes | 217 tokens | Cum: 1011 tkns (12.64% of 8k)
==========================================================================

Showing B1 (chunk 1 of 1): B1:
**The Oncology Institute Announces $16.5 million Private Placement**Date: Unknown DateSource: Unknown SourceURL: https://www.globenewswire.com/news-release/2025/03/24/3047652/0/en/The-Oncology-Institute-Announces-16-5-million-Private-Placement.htmlThe Oncology Institute, Inc. (TOI) announced a $16.5 million private placement with existing investors, management, and directors. The proceeds will be used for organic growth and working capital. The company also entered an exchange agreement with Deerfield Management Company to exchange convertible notes for preferred stock and warrants.

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

TOIIW_OUT_5 [2025-04-24 12:30:56 -0400] 380 Bytes | 87 tokens | Cum: 1100 tkns (13.75% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

TOIIW_OUT_7 [2025-04-24 12:30:57 -0400] 336 Bytes | 98 tokens | Cum: 1200 tkns (15.00% of 8k)
==========================================================================

Showing A1 (chunk 1 of 1): A1:
Document A1 not found. Only 0 articles available.

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

TOIIW_OUT_9 [2025-04-24 12:30:58 -0400] 238 Bytes | 59 tokens | Cum: 1261 tkns (15.76% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

TOIIW_OUT_11 [2025-04-24 12:30:58 -0400] 318 Bytes | 94 tokens | Cum: 1357 tkns (16.96% of 8k)
==========================================================================

Showing S1 (chunk 1 of 1): S1:
No SEC filing available for S1.

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

TOIIW_OUT_13 [2025-04-24 12:31:13 -0400] 4189 Bytes | 1140 tokens | Cum: 2499 tkns (31.24% of 8k)
==========================================================================

This is our set of metrics for The Oncology Institute.
Please analyze the numbers.

No Finviz metrics available.

The next section covers any insider trading by The Oncology Institute officers or majority shareholders (if available).

[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): {'value': 393412000.0, 'unit': 'USD', 'label': 'Revenues', 'order': 100}
Net Income: {'value': -64663000.0, 'unit': 'USD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 0.1762
Average Volume: 44270.73
30-Day High: 0.1762
30-Day Low: 0.0234

[Detailed Financials: TTM 2024]
- Total Assets: $172,717,000.00
- Total Liabilities: $169,128,000.00
- Total Equity: $3,589,000.00
- Current Assets: $112,418,000.00
- Current Liabilities: $52,215,000.00

[Income Statement: TTM 2024]
- Revenue: $393,412,000.00
- Net Income: $-64,663,000.00
- Gross Profit: N/A
- Operating Income: $-60,118,000.00
- Earnings Per Share (EPS): -0.71

[Cash Flow Statement: TTM 2024]
- Net Cash Flow: $16,181,000.00

[Detailed Financials: FY 2024]
- Total Assets: $172,717,000.00
- Total Liabilities: $169,128,000.00
- Total Equity: $3,589,000.00
- Current Assets: $112,418,000.00
- Current Liabilities: $52,215,000.00

[Income Statement: FY 2024]
- Revenue: $393,412,000.00
- Net Income: $-64,663,000.00
- Gross Profit: N/A
- Operating Income: $-60,118,000.00
- Earnings Per Share (EPS): -0.71

[Cash Flow Statement: FY 2024]
- Net Cash Flow: $16,181,000.00
==== END OF FINANCIAL REPORT ====

You are now requested to write a summary analysis of The Oncology Institute (TOIIW).

Please complete the report using the exact format:
FIELD[value]

1) BRIEF_SUMMARY[]
One well-worded paragraph summarizing your findings about The Oncology Institute.

2) MARKET_SCORE[]
This conversation was initiated because TOIIW is currently experiencing upward price and volume movement.
Estimate a number between 1–100 based on the likelihood of a continued upward price move for TOIIW.
Weigh relevant data — news, filings, fundamentals, and metrics — and assign appropriate weight.

3) PRICE_TARGET[]
Suggest a price, based on all prior evidence and past price behavior, TOIIW could reach in the current or upcoming trading sessions (1–5 days).
For example, if you expect TOIIW to increase 50% from its current price of $0.00, say: PRICE_TARGET[0.0]

4) AI_RPT_HEADLINE[]
Write a thought-provoking 8–12 word headline summarizing this report.

5) SQUEEZE_POTENTIAL[]
Give a score from 1 to 100 representing the potential for this stock to become an active short squeeze play.
Be honest and unbiased. Consider short interest/float, price movement, volume, news strength, and volatility potential.

6) TAGS[]
List 3–6 comma-separated tags (e.g., biotech, earnings beat, squeeze setup)

7) STOCK_TYPE[]
Choose the most accurate classification: growth, value, turnaround, hype, squeeze, dividend, speculative, or other.

8) PRIMARY_CATALYST[]
e.g., earnings report, FDA approval, partnership, etc.

9) SENTIMENT[]
bullish, bearish, neutral, or mixed

10) IMPROVEMENT_SUGGESTION[]
If you believe some key info was missing, state what would have significantly improved your analysis of The Oncology Institute.

11) ETHICAL_RATING[]
Rate The Oncology Institute’s alignment with long-term shareholder interests, using a letter grade from A (high alignment) to F (low alignment).
Base this on actions such as insider buying/selling, share dilution, follow-through on public statements, and compensation practices.

12) UPCOMING_CATALYST[]
Specify any upcoming events you expect would be a catalyst affecting the share-price of The Oncology Institute.
Provide any reasons you can use to support it.

Return only: FIELD[value] for each of the above 12 questions.
Respond with all data pairs. Take your best guess if you have to, but don't leave blank items.
Do not explain your answers. Return only the required fields in the exact format shown.

Finally, thank you for participating!

TOIIW_IN_15 [2025-04-24 12:31:13 -0400] 126 Bytes | 29 tokens | Cum: 2778 tkns (34.73% of 8k)
==========================================================================

====================================
[2025-04-24 12:31:13] # Analysis Completed
Elapsed Time: 19.93 seconds